azacitidine has been researched along with Bone Neoplasms in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 14 (66.67) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Barkauskas, DA; Chow, WY; Farrar, JE; Gerhard, D; Gorlick, R; Guerra, R; Guidry Auvil, JM; Hicks, MJ; Lau, CC; Man, TK; Meltzer, P; Nakka, M; Ng, PKS; Shen, J; Sun, JM; Taylor, AM; Xu, G; Yu, A | 1 |
| Bouvet, M; Han, Q; Hayashi, K; Higuchi, T; Hoffman, RM; Igarashi, K; Kimura, H; Kuchipudi, S; Miwa, S; Oshiro, H; Singh, SR; Sugisawa, N; Tan, Y; Tsuchiya, H; Yamamoto, J; Yamamoto, N | 1 |
| Cheng, T; Guo, W; Ruan, F; Wei, B; Xiang, M; Xu, X | 1 |
| Desiderio, V; La Noce, M; Lombardi, A; Mele, L; Paino, F; Papaccio, F; Papaccio, G; Regad, T; Tirino, V | 1 |
| Bendinelli, P; Desiderio, MA; Locatelli, A; Maroni, P; Matteucci, E | 1 |
| Guo, QN; Huang, Y; Li, Y; Lv, Y; Meng, G | 1 |
| Chen, H; Geng, P; Huang, L; Jiang, W; Li, Y; Lin, X; Liu, J; Su, B; Wang, Y; Yao, J | 1 |
| Li, B; Li, H; Sun, L; Ye, Z; Yuan, L; Zhang, J; Zhu, X | 1 |
| Alholle, A; Bauer, J; Brini, AT; Gentle, D; Gharanei, S; Grimer, R; Jeys, L; Latif, F; Maher, ER; Niada, S; Slater, A; Sumathi, VP | 1 |
| Bendinelli, P; Desiderio, MA; Disanza, A; Maroni, P; Matteucci, E | 1 |
| Borinstein, SC; Hawkins, AG; Laird, PW; Lawlor, ER; Martens, JR; Punj, V; Ryland, KE; Weisenberger, DJ | 1 |
| Katula, KS; Rumph, C; Vaidya, H | 1 |
| Balaji, KC; Lin, HK; Liu, Y; Pochampally, R; Said, N; Sharma, S; Shiozawa, Y; Watabe, K; Wu, K; Xing, F | 1 |
| Clemens, D; Dirksen, U; Hotfilder, M; Klco-Brosius, S; Pettke, A; Potratz, J; Schaefer, C | 1 |
| Bendinelli, P; Desiderio, MA; Maroni, P; Matteucci, E | 1 |
| Cornfield, DB | 1 |
| Catto, JW; Cross, SS; Hamdy, FC; Leiblich, A; Leung, HY; Phillips, JT; Rehman, I | 1 |
| Al-Romaih, K; Sadikovic, B; Squire, JA; Wang, Y; Yoshimoto, M; Zielenska, M | 1 |
| Glaubiger, DL; LeVine, AS; Poplack, DG; Reaman, GH; Srinivasan, U | 1 |
| Locklin, RM; Oreffo, RO; Triffitt, JT | 1 |
| Debatin, KM; Dockhorn-Dworniczak, B; Fulda, S; Küfer, MU; Meyer, E; van Valen, F | 1 |
21 other study(ies) available for azacitidine and Bone Neoplasms
| Article | Year |
|---|---|
The Role of FAS Receptor Methylation in Osteosarcoma Metastasis.
Topics: Animals; Azacitidine; Bone Neoplasms; Cell Line, Tumor; CpG Islands; DNA Methylation; fas Receptor; Mice; Osteosarcoma | 2023 |
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model.
Topics: Adolescent; Animals; Antineoplastic Agents; Azacitidine; Bone Neoplasms; Carbon-Sulfur Lyases; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Drug Resistance, Neoplasm; Heterografts; Humans; Male; Mice; Mice, Nude; Osteosarcoma; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
The Na+/K+ ATPase Inhibitor Ouabain Attenuates Stemness and Chemoresistance of Osteosarcoma Cells.
Topics: Azacitidine; Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; DNA Methylation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Neoplasm Invasiveness; Neoplastic Stem Cells; Osteosarcoma; Ouabain; Sodium-Potassium-Exchanging ATPase | 2019 |
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
Topics: Animals; Azacitidine; Bone Neoplasms; Cell Line, Tumor; DNA Methylation; Heterografts; Histone Deacetylase 2; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Osteosarcoma; Transfection; Valproic Acid | 2018 |
Epigenetic control of endothelin-1 axis affects invasiveness of breast carcinoma cells with bone tropism.
Topics: Azacitidine; Bone Neoplasms; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Movement; Collagen; Dactinomycin; DNA Methylation; Drug Combinations; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Laminin; Mutation; Neoplasm Invasiveness; Peptides, Cyclic; Proteoglycans; Proto-Oncogene Protein c-ets-1; Receptor, Endothelin A; RNA Stability; RNA, Messenger; Transcription, Genetic | 2013 |
Epigenetic regulation of the pro-apoptosis gene TSSC3 in human osteosarcoma cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Nuclear Proteins; Osteosarcoma; Promoter Regions, Genetic; Up-Regulation | 2014 |
Enhancement of radiosensitivity by 5-Aza-CdR through activation of G2/M checkpoint response and apoptosis in osteosarcoma cells.
Topics: 14-3-3 Proteins; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Biomarkers, Tumor; Bone Neoplasms; Cell Division; Cell Line, Tumor; Checkpoint Kinase 2; Death-Associated Protein Kinases; Decitabine; Exoribonucleases; G2 Phase; Gene Expression Regulation, Neoplastic; Humans; Osteosarcoma; Radiation Tolerance | 2014 |
Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Blotting, Western; Bone Neoplasms; CD8-Positive T-Lymphocytes; Cell Proliferation; Decitabine; Female; Flow Cytometry; Humans; Immunotherapy; Membrane Proteins; Mice; Mice, SCID; Neoplasm Proteins; Osteosarcoma; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured | 2014 |
Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Bone Neoplasms; Cell Line, Tumor; Chordoma; Decitabine; DNA Methylation; Female; Gene Expression; Genome; Humans; Male; Middle Aged; Recurrence | 2015 |
Coordinate regulation of microenvironmental stimuli and role of methylation in bone metastasis from breast carcinoma.
Topics: Animals; Azacitidine; Bone Neoplasms; Breast Neoplasms; DNA Methylation; DNA, Neoplasm; Endothelin-1; Female; Humans; Mice; Mice, Nude; MicroRNAs; Neoplasm Metastasis; Neoplasm Proteins; Osteonectin; RNA, Neoplasm; Tumor Microenvironment | 2016 |
Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.
Topics: Azacitidine; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Kv1.5 Potassium Channel; Promoter Regions, Genetic; Sarcoma, Ewing | 2016 |
Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
Topics: Azacitidine; Bone Neoplasms; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; DNA Methylation; DNA, Neoplasm; Exons; Gene Expression Regulation, Neoplastic; Genes, Reporter; Histone Code; Humans; Luciferases, Renilla; Methylation; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Osteoblasts; Osteosarcoma; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Recombinant Fusion Proteins; Transfection; Wnt Proteins; Wnt Signaling Pathway; Wnt-5a Protein | 2016 |
Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Topics: Animals; Azacitidine; Bone Morphogenetic Protein 7; Bone Neoplasms; Cell Line, Tumor; DNA Methylation; DNA, Neoplasm; Humans; Male; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Transplantation; Osteonectin; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Prostatic Neoplasms; Tumor Microenvironment | 2016 |
Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Osteosarcoma; Vorinostat | 2016 |
Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma.
Topics: Animals; Azacitidine; Bone Neoplasms; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Nucleus; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Nuclear Proteins; Proto-Oncogene Proteins c-met; Signal Transduction; Tumor Microenvironment; Tumor Suppressor Proteins | 2017 |
Erythroblastic sarcoma, an extremely rare variant of myeloid sarcoma.
Topics: Abnormal Karyotype; Adenocarcinoma; Aged; Azacitidine; Biopsy, Large-Core Needle; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Erythroblasts; Erythropoietin; Fatal Outcome; Humans; Lymph Nodes; Male; Myelodysplastic Syndromes; Rare Diseases; Rectal Neoplasms; Sarcoma, Myeloid | 2012 |
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
Topics: Amino Acid Sequence; Azacitidine; Base Sequence; Bone Neoplasms; Decitabine; DNA Methylation; DNA Modification Methylases; DNA, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Molecular Sequence Data; Promoter Regions, Genetic; Prostatic Neoplasms; Proteomics; Tumor Cells, Cultured | 2006 |
Decitabine-induced demethylation of 5' CpG island in GADD45A leads to apoptosis in osteosarcoma cells.
Topics: Animals; Apoptosis; Azacitidine; Blotting, Western; Bone Neoplasms; Cell Cycle Proteins; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Nude; Nuclear Proteins; Osteoblasts; Osteosarcoma; RNA, Small Interfering; Transplantation, Heterologous; Tumor Cells, Cultured | 2008 |
Phase II study of 5-azacytidine in sarcomas of bone.
Topics: Adolescent; Adult; Azacitidine; Bone Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Neoplasm Metastasis; Neutropenia; Osteosarcoma; Platelet Count; Sarcoma, Ewing; Thrombocytopenia | 1982 |
Modulation of osteogenic differentiation in human skeletal cells in Vitro by 5-azacytidine.
Topics: Alkaline Phosphatase; Azacitidine; Biomarkers; Bone Marrow Cells; Bone Neoplasms; Cell Differentiation; Cells, Cultured; DNA; DNA Methylation; Female; Humans; Male; Middle Aged; Osteoblasts; Osteogenesis; Osteosarcoma; Proteins; Stromal Cells; Tumor Cells, Cultured | 1998 |
Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Bone Neoplasms; Caspase 3; Caspase 8; Caspase 9; Caspases; Decitabine; DNA Modification Methylases; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Induction; Gene Transfer Techniques; Humans; Membrane Glycoproteins; Methylation; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; RNA, Messenger; Sarcoma, Ewing; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2001 |